BioWorld

Feb. 20, 2007

View Archived Issues

Ziopharm Adds $31M For Clinical Oncology Pipeline

Ziopharm Oncology Inc. pulled in gross proceeds of $30.9 million in a private placement to advance ongoing clinical development of three lead cancer programs, two of which are expected enter pivotal testing this year. (BioWorld Today) Read More

Inspire Pads Late-Stage Pipeline With License To InSite's AzaSite

Read More

In Irritable Bowel Syndrome Pain, A General Mechanism

Read More

FDA Says No Strings Attached To PDUFA At Public Meeting

Read More

Holiday Notice

Read More

GPC's Satraplatin NDA Done, Drug Could Launch This Year

Read More

Other News To Note

Read More

Appointments And Advancements

Read More